Abstract
Sweet syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by tender, red inflammatory nodules or papules that occur in association with infection, malignancy, connective tissue disease, or following exposure to certain drugs. Although drug-induced Sweet syndrome is rare, granulocyte colony-stimulating factor, all-trans-retinoic acid, and miscellaneous drugs have been implicated in causing this disorder in adults. In pediatric patients, granulocyte colony-stimulating factor, all-trans-retinoic acid, trimethoprim-sulfamethoxazole, and azathioprine have been implicated as potential causes of drug-induced Sweet syndrome. To date, six cases, including the patient reported here, have been reported in children.
Similar content being viewed by others
Abbreviations
- SS:
-
Sweet syndrome
- c-ANCA:
-
c-type anti-neutrophil cytoplasmic antibody
- TPMT:
-
Thiopurine methyltransferase
- GCSF:
-
Granulocyte colony-stimulating factor
References
Abecassis S, Ingen-Housz-Oro S, Cavelier-Balloy B et al (2004) Particular histological features of a case of Sweet’s syndrome induced by G-CSF. Ann Dermatol Vénéréol 131:369–372
Aguiar-Bujanda D, Aguiar-Morales J, Bohn-Sarmiento U (2004) Sweet’s syndrome associated with norfloxacin in a prostate cancer patient. QJM 97:55–56
Ahn SJ, Choi JH, Sung KJ et al (2000) Sweet’s syndrome presenting with lesions resembling eruptive xanthoma. Br J Dermatol 143:449–450
Al-Saad K, Khanani MF, Naqvi A et al (2004) Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pediatr Hematol Oncol 26:197–199
Alvaro T, Garcia del Moral R, Gomez-Morales M et al (1991) Immunopathological studies of Sweet’s syndrome. Br J Dermatol 124:111–112
Arbetter KR, Hubbard KW, Markovic SN et al (1999) Case of granulocyte colony-stimulating factor-induced Sweet’s syndrome. Am J Hematol 61:126–129
Bianchi L, Masi M, Hagman JH et al (1999) Systemic interferon-alpha treatment for idiopathic Sweet’s syndrome. Clin Exp Dermatol 24:443–445
Bidyasar S, Montoya M, Suleman K et al (2008) Sweet syndrome associated with granulocyte colony-stimulating factor. J Clin Oncol 26:4355–4356
Boatman BW, Taylor RC, Klein LE et al (1994) Sweet’s syndrome in children. South Med J 87:193–196
Christ E, Linka A, Jacky E et al (1996) Sweet’s syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. Leukemia 10:731–734
Cobb MW (1989) Furosemide-induced eruption simulating Sweet’s syndrome. J Am Acad Dermatol 21:339–343
Cohen PR (2007) Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2:34
Cohen PR, Almeida L, Kurzrock R (1989) Acute febrile neutrophilic dermatosis. Am Fam Physician 39:199–204
Cohen PR, Kurzrock R (1993) Sweet’s syndrome and cancer. Clin Dermatol 11:149–157
Cohen PR, Kurzrock R (2000) Sweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol 18:265–282
Cohen PR, Kurzrock R (2003) Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol 42:761–778
Cohen PR, Talpaz M, Kurzrock R (1988) Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol 6:1887–1897
Corbett M, Schlup M (2001) Azathioprine hypersensitivity mimicking underlying inflammatory bowel disease. Intern Med J 31:366–367
Cox NH, O’Brien HA (1994) Sweet’s syndrome associated with trans-retinoic acid treatment in acute promyelocytic leukaemia. Clin Exp Dermatol 19:51–52
de Fonclare AL, Khosrotehrani K, Aractingi S et al (2007) Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease. Arch Dermatol 143:744–748
Del Giudice P, Vandenbos F, Perrin C et al (2004) Sweet’s syndrome following abacavir therapy. J Am Acad Dermatol 51:474–475
Dunn TR, Saperstein HW, Biederman A et al (1992) Sweet syndrome in a neonate with aseptic meningitis. Pediatr Dermatol 9:288–292
El-Azhary RA (2003) Azathioprine: current status and future considerations. Int J Dermatol 42:335–341
El-Azhary RA, Brunner KL, Gibson LE (2008) Sweet syndrome as a manifestation of azathioprine hypersensitivity. Mayo Clin Proc 83:1026–1030
Fett DL, Gibson LE, Su WP (1995) Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 70:234–240
Fitzgerald RL, McBurney EI, Nesbitt LT Jr (1996) Sweet’s syndrome. Int J Dermatol 35:9–15
Fye KH, Crowley E, Berger TG et al (2001) Celecoxib-induced Sweet’s syndrome. J Am Acad Dermatol 45:300–302
Garey KW, Streetman DS, Rainish MC (1998) Azathioprine hypersensitivity reaction in a patient with ulcerative colitis. Ann Pharmacother 32:425–428
Garty BZ, Levy I, Nitzan M et al (1996) Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type Ib. Pediatrics 97:401–403
Gilmour E, Chalmers RJ, Rowlands DJ (1995) Drug-induced Sweet’s syndrome (acute febrile neutrophilic dermatosis) associated with hydralazine. Br J Dermatol 133:490–491
Ginarte M, Garcia Doval I, Toribio J (1997) Sweet’s syndrome: a study of 16 cases. Med Clin (Barc) 109:588–591
Going JJ, Going SM, Myskow MW et al (1987) Sweet’s syndrome: histological and immunohistochemical study of 15 cases. J Clin Pathol 40:175–179
Gray LC, Abele DC (1998) Annular erythematous plaques and tibial pain in a child. Sweet syndrome. Arch Dermatol 134(625–626):628–629
Guimera FJ, Garcia-Bustinduy M, Noda A et al (2000) Diazepam-associated Sweet’s syndrome. Int J Dermatol 39:795–798
Gyorfy A, Kovacs T, Szegedi I et al (2003) Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy. Med Pediatr Oncol 40:135–136
Halpern J, Salim A (2009) Pediatric sweet syndrome: case report and literature review. Pediatr Dermatol 26:452–457
Howard R, Tsuchiya A (1998) Adult skin disease in the pediatric patient. Dermatol Clin 16:593–608
Itami S, Nishioka K (1980) Sweet’s syndrome in infancy. Br J Dermatol 103:449–451
Jordaan HF (1989) Acute febrile neutrophilic dermatosis. A histopathological study of 37 patients and a review of the literature. Am J Dermatopathol 11:99–111
Klock JC, Oken RL (1976) Febrile neutrophilic dermatosis in acute myelogenous leukemia. Cancer 37:922–927
Knowles S, Shear NH (1997) Azathioprine hypersensitivity reactions: caution upon rechallenge. Muscle Nerve 20:1467–1468
Kumar G, Bernstein JM, Waibel JS et al (2004) Sweet’s syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment. Am J Hematol 76:283–285
Magro CM, Crowson AN (1997) A distinctive vesiculopustular eruption associated with hepatobiliary disease. Int J Dermatol 36:837–844
Majeed HA, Kalaawi M, Mohanty D et al (1989) Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr 115:730–734
McGovern DP, Travis SP, Duley J et al (2002) Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity. Gastroenterology 122:838–839
McLeod HL, Krynetski EY, Relling MV et al (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14:567–572
Mensing H, Kowalzick L (1991) Acute febrile neutrophilic dermatosis (Sweet’s syndrome) caused by minocycline. Dermatologica 182:43–46
Miller RM, Darben TA, Nedwich J et al (1999) Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves’ disease and a neutrophilic dermatosis. Br J Dermatol 141:943–944
Morgan KW, Callen JP (2001) Sweet’s syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells. J Am Acad Dermatol 45:590–595
Noda K, Okuma Y, Fukae J et al (2001) Sweet’s syndrome associated with encephalitis. J Neurol Sci 188:95–97
Otheo E, Ros P, Vazquez JL et al (2002) Systemic inflammatory response syndrome associated with Sweet’s syndrome. Pediatr Crit Care Med 3:190–193
Ozdemir D, Korkmaz U, Sahin I et al (2006) Ofloxacin induced Sweet’s syndrome in a patient with Crohn’s disease. J Infect 52:e155–e157
Paoluzi OA, Crispino P, Amantea A et al (2004) Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet’s syndrome. Case report and review of literature. Dig Liver Dis 36:361–366
Parsapour K, Reep MD, Gohar K et al (2003) Familial Sweet’s syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol 49:132–138
Piette WW, Trapp JF, O’Donnell MJ et al (1994) Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy. J Am Acad Dermatol 30:293–297
Retief CR, Malkinson FD (1999) Nitrofurantoin-associated Sweet’s syndrome. Cutis 63:177–179
Sarkany RP, Burrows NP, Grant JW et al (1998) The pustular eruption of ulcerative colitis: a variant of Sweet’s syndrome? Br J Dermatol 138:365–366
Saxe N, Gordon W (1978) Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Four case reports. S Afr Med J 53:253–256
Schonfeldt-Lecuona C, Connemann BJ (2002) Sweet’s syndrome and polyserositis with clozapine. Am J Psychiatry 159:1947
Shimizu T, Yoshida I, Eguchi H et al (1996) Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony-stimulating factor. J Pediatr Hematol Oncol 18:282–284
Sinico RA, Sabadini E, Borlandelli S et al (2003) Azathioprine hypersensitivity: report of two cases and review of the literature. J Nephrol 16:272–276
Sitjas D, Puig L, Cuatrecasas M et al (1993) Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Int J Dermatol 32:261–268
Su WP, Liu HN (1986) Diagnostic criteria for Sweet’s syndrome. Cutis 37:167–174
Sweet RD (1964) An acute febrile neutrophilic dermatosis. Br J Dermatol 76:349–356
Tefany FJ, Georgouras K (1991) A neutrophilic reaction of Sweet’s syndrome type associated with the oral contraceptive. Australas J Dermatol 32:55–59
Thibault MJ, Billick RC, Srolovitz H (1992) Minocycline-induced Sweet’s syndrome. J Am Acad Dermatol 27:801–804
Thompson DF, Montarella KE (2007) Drug-induced Sweet’s syndrome. Ann Pharmacother 41:802–811
Thompson MA, Dyson SW, Faderl S (2006) Sweet’s syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor. Am J Hematol 81:703–705
Tomas JF, Escudero A, Fernandez-Ranada JM (1994) All-trans retinoic acid treatment and Sweet syndrome. Leukemia 8:1596
Uhara H, Saida T, Nakazawa H et al (2008) Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor. J Am Acad Dermatol 59:S10–S12
Veres K, Haraszti A, Nemes Z et al (1999) Sweet syndrome following therapeutic use of granulocyte colony stimulating factor. Orv Hetil 140:1059–1061
von den Driesch P (1994) Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31:535–556, quiz 557–560
Walker DC, Cohen PR (1996) Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol 34:918–923
White JM, Mufti GJ, Salisbury JR et al (2006) Cutaneous manifestations of granulocyte colony-stimulating factor. Clin Exp Dermatol 31:206–207
Yiasemides E, Thom G (2009) Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis. Australas J Dermatol 50:48–51
Ytting H, Vind I, Bang D et al (2005) Sweet’s syndrome-an extraintestinal manifestation in inflammatory bowel disease. Digestion 72:195–200
Acknowledgment
There was no grant support for this article.
Conflict of interests
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, M.J., Choe, Y.H. EPONYM. Eur J Pediatr 169, 1439–1444 (2010). https://doi.org/10.1007/s00431-010-1201-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-010-1201-z